DIFFERENTIAL DIAGNOSIS
- 1 of the 5 “F” causes of abdominal swelling:
- Fluid (including cysts)
- Fat
- Flatus
- Fetus
- Feces
- Other: Organomegaly
- Serum-ascites albumin gradient (SAAG) = serum albumin – ascitic albumin:
- Replaced ascitic fluid total protein in the differential diagnosis of ascites
- SAAG ≥1.1 g/dL:
- 97% accurate in predicting portal hypertension
- Cirrhosis
- Alcoholic hepatitis
- Cardiac
- Liver metastases
- Fulminant hepatic failure
- Portal vein thrombosis
- Veno-occlusive disease
- Myxedema
- Budd—Chiari
- Fatty liver of pregnancy
- SBP
- SAAG <1.1 g/dL:
- Peritoneal carcinomatosis
- TB
- Pancreatic ascites
- Nephrotic syndrome
- Bowel obstruction or infarction
- Vasculitis
- Postoperative lymphatic leak
TREATMENT
PRE HOSPITAL
Symptomatic hypotension:
- Airway, breathing, circulation (ABCs), IV 0.9 NS
INITIAL STABILIZATION/THERAPY
Sudden increase in abdominal girth, pain, or fever requires urgent evaluation for possible complicating factor such as:
- Infection
- Hepatoma
- Obstruction of hepatic outflow
- Decompensated liver function
ED TREATMENT/PROCEDURES
- Successful treatment depends on accurate diagnosis of underlying cause.
- Treat underlying cause.
- Minimize ascitic fluid and peripheral edema without causing intravascular volume depletion.
- Early detection of complications is necessary:
- SBP:
- High degree of suspicion
- Low threshold for paracentesis
- Prompt therapy
- Tense ascites and hydrothorax:
- Supplemental oxygen
- Therapeutic paracentesis or thoracentesis for respiratory distress
- Abdominal hernias:
- Watch for incarceration, ulceration, or rupture.
- Therapeutic paracentesis
- Surgical consultation
- Persistent leak at paracentesis site:
- Remove more fluid.
- Stomal barrier device
- Meralgia paresthetica:
- Owing to pressure on the lateral femoral cutaneous nerve
- Relieve the pressure by paracentesis or diuresis.
- Large-volume paracentesis:
- 5–10 L (100 mL/kg)
- Performed safely in the ED with stable hemodynamics
- Consider replacement with IV albumin (5–10 g/L fluid removed) if >5 L removed.
- Monitor the patient for 8 hr prior to discharge.
- Nonparacentesis reduction of ascites:
- Strict sodium restriction:
- <2 g/day
- Restrict water if serum sodium <120–125 mEq/L
- Spironolactone:
- Works best for cirrhotic ascites
- Alternatives: Amiloride or triamterene
- Furosemide:
- Works best for other causes of ascites
- Add to spironolactone in cirrhotics at spironolactone/furosemide ratio of 100 mg/40 mg.
- Add metolazone for less responsive cases.
- Diuretic principles:
- Administer diuretics as single morning dose.
- Obtain spot-urine sodium to evaluate response.
- Patients with urinary Na >10 mEq/L are more responsive to diuretics.
- Diuretic-induced weight loss should not exceed 2 lb/day in patients without edema and 5 lb/day in patients with edema.
- Monitor electrolytes and renal function.
- Avoid hypokalemia since hypokalemia enhances renal ammonia production, precipitating hepatic encephalopathy.
- Refractory ascites:
- Accounts for 10% of patients
- Ensure compliance with diet and medications.
- Treated with peritoneovenous shunt—transjugular intrahepatic portosystemic shunt
- Liver transplantation
- Avoid NSAIDs:
- Diminish response to diuretics
- Decrease renal plasma flow and GFR.
- Cause sodium retention/reduces urinary Na excretion
- Treat underlying cause of ascites owing to conditions other than cirrhosis:
MEDICATION
First Line
- Albumin: 5–10 g/L of fluid removed if >5 L removed
- Cefotaxime: 2 g IV q8h
- Spironolactone: 100–400 mg/d (peds: 1–6 mg/kg) PO in 2 divided doses per day
- Furosemide: 40–160 mg/d (peds: 1–3 mg/kg) PO
Second Line
- Amiloride: 5–20 mg/d PO
- Metolazone: 5 mg/d
- Triamterene: 100–300 mg/d PO in 2 divided doses per day
FOLLOW-UP
DISPOSITION
Admission Criteria
- Fulminant liver failure
- Hepatic encephalopathy
- SBP
- Hepatorenal syndrome
- GI bleeding
- Tense ascites not responding to ED treatment
Discharge Criteria
Patients responding to ED management
FOLLOW-UP RECOMMENDATIONS
- GI for all new cases
- Primary doctor or GI for previously established cases
PEARLS AND PITFALLS
- New cases need full workup and GI consultation for management.
- SBP symptoms are frequently vague.
- Must have a high suspicion and low threshold for paracentesis when considering SBP
- Benefits of confirming SBP outweigh risks of bleeding in a coagulopathic patient undergoing paracentesis.
- US guidance is helpful when performing paracentesis in lower-volume ascites.
ADDITIONAL READING
- Feldman M.
Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
. 9th ed. Philadelphia, PA: WB Saunders; 2010.
- Runyon BA; AASLD Practice Guidelines Committee. Management of Adult Patients with Ascites Due to Cirrhosis: An update.
Hepatology
. 2009; 49:2087–2107.
- Runyon B, Such J.
Initial Therapy of Ascites in Patients with Cirrhosis
.
UpToDate
, 2012.
- Corey K, Friedman L.
Harrison’s Principles of Internal Medicine.
18th ed. New York, NY: McGraw-Hill; 2012.
See Also (Topic, Algorithm, Electronic Media Element)
Cirrhosis
CODES
ICD9
- 789.5 Ascites
- 789.51 Malignant ascites
- 789.59 Other ascites
ICD10
- R18 Ascites
- R18.0 Malignant ascites
- R18.8 Other ascites
ASTHMA, ADULT
Melissa H. White
•
Carolyn Maher Overman
BASICS
DESCRIPTION
- Increased expiratory resistance:
- Airway inflammation
- Bronchospasm
- Mucosal edema
- Mucous plugging
- Smooth muscle hypertrophy
- Consequences:
- Air trapping
- Airway remodeling
- Increased dead space
- Hyperinflation
- Status asthmaticus refers to disease that does not respond to therapy within 30–60 min
- Risk factors for life-threatening disease:
- Prior intubations
- Intensive care unit admissions
- Chronic steroid use
- Hospital admission for asthma during the past year
- Inadequate medical management
- Increasing age
- Ethnicity (African Americans)
- Lack of access to medical care
- Multiple comorbidities